MEETINGS - ATA 2001 (US): June 2001:
This article was originally published in Clinica
ATA 2001 is the title of the American Telemedicine Association's 6th annual meeting and exposition, being held in Fort Lauderdale, Florida, on June 3-6. ATA 2001 will address a number telemedicine applications and interest areas such as cardiology, correctional care, dermatology, distance learning, e-health and internet-based applications, homecare and patient monitoring, legal, policy and regulatory issues, ocular health, radiology, pathology and imaging, and surgery. For more information, contact the ATA in the US. Tel: +1 202 223 3333. Fax: +1 202 223 2787. Email: email@example.com www.americantelemed.org
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.